Clinical Trials Browser

Phase 2 × Small Bowel Adenocarcinoma × 1 year × Clear all

NCT06835387 2026-06-04

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Phase 2 Recruiting

Gastrointestinal

Small Bowel Adenocarcinoma